Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most ...
Some 68% of patients with autoimmune disease had "major" side effects from CAR-T therapy for myeloma, lymphoma, or leukemia, ...
Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and ...
After months of putting off a blood draw, Austin hairdresser encouraged by client to get test for leukemia after months of ...
Researchers from the Alliance for Clinical Trials in Oncology have found that two targeted immunotherapy drugs lead to high remission rates and long ...
Canonization of the Roman Catholic Saint Carlo shines a spotlight on the near cure of acute promyelocytic leukemia — a rare, ...
Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...
Watch as Gabe Fholer rings the bell to celebrate being cancer-free. Doctors say a breakthrough drug helped make it happen.
Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback